Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Thioredoxin in the cardiovascular system.

Cameron J World1, Hideyuki Yamawaki, Bradford C Berk

  • 1Cardiovascular Research Institute, Department of Medicine, University of Rochester, Rochester, NY, USA.

Journal of Molecular Medicine (Berlin, Germany)
|October 6, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Endothelial-to-mesenchymal transition (EndMT) in atherosclerosis: mechanisms, models and therapies.

Cardiovascular research·2026
Same author

Endothelial cell RpL17-dependent translational control mediates intima-media thickening in response to disturbed flow.

bioRxiv : the preprint server for biology·2026
Same author

Corrigendum to "Impaired spine formation and learning in GPCR kinase 2 interacting protein-1 (GIT1) knockout mice" [Brain Res. 1317 (2010) 218-26].

Brain research·2026
Same author

Minocycline inhibits endothelin-1-induced contraction in isolated pulmonary artery.

Journal of pharmacological sciences·2026
Same author

Novel organoid-based exploration reveals the role of LMTK3/FADS2 signaling in metastatic breast cancer progression in felines and humans.

Scientific reports·2025
Same author

PDE10A Inhibition Disrupts Lipid Droplet Formation and Sensitizes Macrophages to Ferroptosis after LPS treatment.

bioRxiv : the preprint server for biology·2025
Same journal

Non-transferrin-bound iron uptake by cardiomyocytes.

Journal of molecular medicine (Berlin, Germany)·2026
Same journal

Beyond the target: implications of Wnt pathway inhibitors on bone health.

Journal of molecular medicine (Berlin, Germany)·2026
Same journal

Proteomic analysis reveals divergent inflammatory mechanisms of COVID-associated Guillain-Barré syndrome.

Journal of molecular medicine (Berlin, Germany)·2026
Same journal

Integrative genetic and functional analysis of autosomal dominant hearing loss in 108 multigenerational families.

Journal of molecular medicine (Berlin, Germany)·2026
Same journal

Preclinical evaluation of cysteine protease-inhibitor aloxistatin (E64d) for heart failure therapy.

Journal of molecular medicine (Berlin, Germany)·2026
Same journal

Zinc-binding protein metallothionein 3 protects vascular smooth muscle cells from ferroptosis via blocking lysosomal degradation of GPX4.

Journal of molecular medicine (Berlin, Germany)·2026
See all related articles

The thioredoxin (TRX) system is vital for cellular redox balance. Its dysfunction contributes to cardiovascular diseases, highlighting TRX as a potential therapeutic target for oxidative stress-related conditions.

Area of Science:

  • Biochemistry
  • Cellular Biology
  • Cardiovascular Science

Background:

  • The thioredoxin (TRX) system, comprising TRX, TRX reductase, and NADPH, is crucial for maintaining cellular reduction/oxidation (redox) homeostasis.
  • Impaired cellular redox state is implicated in the pathogenesis of cardiovascular disorders like hypertension, atherosclerosis, and heart failure.

Purpose of the Study:

  • To review the critical roles of the thioredoxin system in cellular redox regulation.
  • To explore the involvement of TRX in cardiovascular disease development.
  • To identify TRX and its regulators as potential therapeutic targets.

Main Methods:

  • Literature review of studies on the thioredoxin system and cardiovascular diseases.
  • Analysis of TRX's antioxidant mechanisms, including direct effects and protein-protein interactions.

Related Experiment Videos

  • Examination of TRX's interaction with thioredoxin interacting protein (TXNIP).

    • Main Results:

    • The TRX system is a key regulator of cellular redox balance.
    • TRX mitigates oxidative stress through direct antioxidant activity and modulation of signaling pathways.
    • TRX interacts with TXNIP, influencing cellular responses to oxidative stress.

    Conclusions:

    • The thioredoxin system plays a fundamental role in preventing oxidative stress-induced cellular damage.
    • Dysregulation of the TRX system contributes to cardiovascular pathologies.
    • TRX and its endogenous regulators represent promising targets for novel clinical therapies against oxidative stress-related diseases.